Matthew Parisi

Analyst

KeyBank Capital Markets (on for Paul Knight)

Equibles does not estimate personal net worth.

About Matthew Parisi

Matthew Parisi is recorded as Analyst at KeyBank Capital Markets (on for Paul Knight). Matthew Parisi has spoken on 3 earnings calls across 3 companies, most recently for Castle Biosciences Inc on November 5, 2026. Those appearances were for Castle Biosciences Inc (CSTL), Maravai Lifesciences Holdings, Inc. (MRVI) and Exagen Inc. (XGN). The companies whose calls Matthew Parisi spoke on are classified in the Healthcare sector.

Matthew Parisi on recent calls

“You called out the increase in lab headcount to handle the increase in test volumes that you're seeing. Should we expect to continue to see lab headcount and expenses rise with the rising test volumes, or do you now have the infrastructure in place to be able to kind of handle them going forward?”

Analyst — Key Bank Capital Markets, Castle Biosciences Q3 2026 Earnings Call · November 5, 2026

“You called out that you expected nine customers to transition to GMP throughout 2026, yet 10 have converted year-to-date. Do you expect additional conversions for the remainder of the year?”

Analyst — Key Bank Capital Markets, Q3 2026 Maravai LifeSciences Earnings Conference Call · November 4, 2026

“I'm from Paul Knight over at KeyBank Capital Markets. Thanks for taking my question, and congrats on the quarter. I believe on the last call you called out that ACR was now advocating for the advised CTE test.”

Analyst — Key Bank Capital Markets, Exagen Inc. Q1 FY2026 Earnings Call · May 11, 2026